Gastrocnemius myofascial release for women with knee osteoarthritis
Official title: Effect of Gastrocnemius Myofascial Release on Pain and Physical Function Outcomes in Females With Knee Osteoarthritis
Run by Cairo University · NCT07507175 · Data updated 2026-11-12
This trial will test whether adding gastrocnemius myofascial release to standard physical therapy helps reduce pain and improve function in women 45–55 with knee osteoarthritis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 45 Years to 55 Years |
| Sex | Women only |
| Enrollment | 30 (estimated) |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Giza, Giza Governorate) |
| Status | Recruiting |
| Started | January 3, 2026 |
| Main results expected | July 30, 2026 |
| Study ends | September 30, 2026 |
| Registry record updated | April 2, 2026 |
| Trial ID | NCT07507175 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 45–55 with primary knee osteoarthritis grade II–III (Kellgren–Lawrence), BMI ≤35, current pain ≥4/10, and at least one active gastrocnemius trigger point.
✕Probably not a fit
Patients with advanced (grade IV) knee osteoarthritis, BMI >35, no gastrocnemius trigger points, or significant comorbidities may be unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional trial compares gastrocnemius myofascial release plus conventional physical therapy to sham gastrocnemius myofascial release plus conventional physical therapy in females with knee osteoarthritis. Participants receive real or sham gastrocnemius MFR three times per week for four weeks while both groups undergo standard physical therapy. Outcomes measured include pain, physical function, foot posture, and knee disability assessed before and after the intervention. The single-center trial is conducted at the Faculty of Physical Therapy, Cairo University and enrolls women with radiographic grade II–III knee osteoarthritis, BMI ≤35, and baseline pain of at least 4/10.
Why it matters
Potential benefit: If successful, adding gastrocnemius myofascial release could offer a low-cost, noninvasive way to reduce pain and improve mobility for middle-aged women with knee osteoarthritis.
How similar studies have gone: Small trials and case series have suggested myofascial release can reduce pain and improve function in knee osteoarthritis, but high-quality evidence is limited and results are mixed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients' ages ranged between 45 and 55 years . * BMI ≤35 * Patients with a diagnosis of primary KOA according to the American College of Rheumatology classification at the screening visit . * Onset of symptomatic knee osteoarthritis of ≥3 months * Patients with grade II and III OA of the Kellgren and Lawrence system for classification of osteoarthritis . * At least one active trigger point in GM * If both knees were diagnosed as OA, the most affected one was selected. * Current pain intensity on the Visual Analogue Scale (VAS) ≥4/10. * Subjects have sufficient cognition that enables them to understand the requirements of the study, comply with the study procedures, and visit schedule. * Diagnostic Criteria of KOA A diagnosis of knee osteoarthritis was made when knee pain is present, plus Osteophytes on radiographs, plus at least 1 of the following 3: * Age \> 50 years * Morning stiffness \< 30 minutes * Crepitus on active motion Exclusion Criteria: * Patients with any previous knee surgeries or lower limb fractures. * Chronic inflammatory diseases such as rheumatoid arthritis. * Signs of moderately significant knee synovitis include a warm and swollen (red) knee * History and/or physical examination findings compatible with knee internal derangement (e.g, positive Thessaly test). * Pregnancy * Patients who had undergone arthroscopy or treatment with intra-articular hyaluronic acid during the previous 6 months . * Use of NSAIDs one week before the screening visit . * Orthopedic diseases, or congenital musculoskeletal deformities, or neurological disorders that may affect or interfere with the therapeutic effect. * Participated in other intervention studies (strength training program or physiotherapy treatment for knee osteoarthritis) in the current period and the past 6 months . * Habitual use of psychotropic or narcotic analgesics for ≥1 week within 8 weeks prior to screening .
Where it's running
-
Faculty of Physical Therapy, Cairo University
Giza, Giza Governorate, Egypt Recruiting
Study contacts
- Study coordinator: Hend Hammam Soliman, Bachelor's Degree
- Email: hendhammam18@live.com
- Phone: +201008380834
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of virtual reality on walking in adults with knee osteoarthritis
This study tests how immersive virtual reality environments—designed to feel safe or to provoke fear—affect walking and worry about movement in adults 50 and older with knee osteoarthritis and in healthy peers.
-
Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese
This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).
-
Autologous adipose-derived stem cell injections for knee osteoarthritis
We’re testing whether injecting a patient’s own fat-derived stem cells into the knee can help people with knee OA feel less pain and move better, compared with a standard hyaluronic acid treatment.
-
Preoperative Multimorbidity and Functional Recovery After Total Knee Arthroplasty
This study tests whether higher burden of preoperative multimorbidity affects functional recovery after knee replacement in adults with knee osteoarthritis.
-
Cartilage biomarker response to acute loading in knee OA by antiresorptive treatment status
Researchers will test whether a 30-minute treadmill walk changes cartilage biomarkers in postmenopausal women with knee osteoarthritis, comparing those on denosumab, bisphosphonates, and those not on antiresorptives.
-
Lysyl Enzymes in Knee Osteoarthritis
This study tests whether blood levels of lysyl hydroxylase and lysyl oxidase differ between people with knee osteoarthritis and healthy individuals.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.